Literature DB >> 18672063

The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

K E Soderstrom1, G Meredith, T B Freeman, S O McGuire, T J Collier, C E Sortwell, Qun Wu, K Steece-Collier.   

Abstract

Graft-induced dyskinesias (GIDs), side-effects found in clinical grafting trials for Parkinson's disease (PD), may be associated with the withdrawal of immunosuppression. The goal of this study was to determine the role of the immune response in GIDs. We examined levodopa-induced dyskinesias (LIDs), GID-like behaviors, and synaptic ultrastructure in levodopa-treated, grafted, parkinsonian rats with mild (sham), moderate (allografts) or high (allografts plus peripheral spleen cell injections) immune activation. Grafts attenuated amphetamine-induced rotations and LIDs, but two abnormal motor syndromes (tapping stereotypy, litter retrieval/chewing) emerged and increased with escalating immune activation. Immunohistochemical analyses confirmed immune activation and graft survival. Ultrastructural analyses showed increases in tyrosine hydroxylase-positive (TH+) axo-dendritic synapses, TH+ asymmetric specializations, and non-TH+ perforated synapses in grafted, compared to intact, striata. These features were exacerbated in rats with the highest immune activation and correlated statistically with GID-like behaviors, suggesting that immune-mediated aberrant synaptology may contribute to graft-induced aberrant behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672063      PMCID: PMC2886670          DOI: 10.1016/j.nbd.2008.06.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  65 in total

Review 1.  The role of synaptic morphology in neural plasticity: structural interactions underlying synaptic power.

Authors:  Diano F Marrone; Ted L Petit
Journal:  Brain Res Brain Res Rev       Date:  2002-02

2.  Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias.

Authors:  G E Meredith; I E De Souza; T M Hyde; G Tipper; M L Wong; M F Egan
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.

Authors:  Yilong Ma; Andrew Feigin; Vijay Dhawan; Masafumi Fukuda; Qiuhu Shi; Paul Greene; Robert Breeze; Stanley Fahn; Curt Freed; David Eidelberg
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

4.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

Authors:  C R Freed; P E Greene; R E Breeze; W Y Tsai; W DuMouchel; R Kao; S Dillon; H Winfield; S Culver; J Q Trojanowski; D Eidelberg; S Fahn
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.

Authors:  I Strömberg; J Kehr; B Andbjer; K Fuxe
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

6.  Control of synaptic strength by glial TNFalpha.

Authors:  Eric C Beattie; David Stellwagen; Wade Morishita; Jacqueline C Bresnahan; Byeong Keun Ha; Mark Von Zastrow; Michael S Beattie; Robert C Malenka
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

7.  Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.

Authors:  C E Sortwell; M D Camargo; M R Pitzer; S Gyawali; T J Collier
Journal:  Exp Neurol       Date:  2001-05       Impact factor: 5.330

8.  Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  M A Cenci
Journal:  Amino Acids       Date:  2002       Impact factor: 3.520

9.  Dyskinesias following neural transplantation in Parkinson's disease.

Authors:  Peter Hagell; Paola Piccini; Anders Björklund; Patrik Brundin; Stig Rehncrona; Håkan Widner; Lesley Crabb; Nicola Pavese; Wolfgang H Oertel; Niall Quinn; David J Brooks; Olle Lindvall
Journal:  Nat Neurosci       Date:  2002-07       Impact factor: 24.884

10.  Persistent changes in spinal cord gene expression after recovery from inflammatory hyperalgesia: a preliminary study on pain memory.

Authors:  Rustam Yukhananov; Igor Kissin
Journal:  BMC Neurosci       Date:  2008-03-13       Impact factor: 3.288

View more
  29 in total

Review 1.  The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Authors:  Christopher A Lieu; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2011-09-24       Impact factor: 4.077

2.  Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.

Authors:  Daniella Rylander; Vincenza Bagetta; Valentina Pendolino; Elisa Zianni; Shane Grealish; Fabrizio Gardoni; Monica Di Luca; Paolo Calabresi; M Angela Cenci; Barbara Picconi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

3.  The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats.

Authors:  Timothy P Gilmour; Brigitte Piallat; Christopher A Lieu; Kala Venkiteswaran; Renuka Ramachandra; Anand N Rao; Andrew C Petticoffer; Matthew A Berk; Thyagarajan Subramanian
Journal:  Brain       Date:  2011-09-12       Impact factor: 13.501

4.  Development of histocompatible primate-induced pluripotent stem cells for neural transplantation.

Authors:  Michela Deleidi; Gunnar Hargus; Penelope Hallett; Teresia Osborn; Ole Isacson
Journal:  Stem Cells       Date:  2011-07       Impact factor: 6.277

Review 5.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

6.  Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian Striatum.

Authors:  Kathy Steece-Collier; David J Rademacher; Katherine Soderstrom
Journal:  Basal Ganglia       Date:  2012-02-11

Review 7.  Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Authors:  Yilong Ma; Shichun Peng; Vijay Dhawan; David Eidelberg
Journal:  Br Med Bull       Date:  2011-08-28       Impact factor: 4.291

8.  BDNF in the Aged Brain: Translational Implications for Parkinson's Disease.

Authors:  N M Mercado; T J Collier; C E Sortwell; K Steece-Collier
Journal:  Austin Neurol Neurosci       Date:  2017-09-19

9.  Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats.

Authors:  Kathy Steece-Collier; Katherine E Soderstrom; Timothy J Collier; Caryl E Sortwell; Eleonora Maries-Lad
Journal:  J Comp Neurol       Date:  2009-07-01       Impact factor: 3.215

Review 10.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.